Financial Ratios

ARTEMIS MEDICARE SERVICES LTD.

NSE : ARTEMISMEDBSE : 542919ISIN CODE : INE025R01021Industry : Hospital & Healthcare ServicesHouse : Raunaq Singh
BSE178.40-5.6 (-3.04 %)
PREV CLOSE ( ) 184.00
OPEN PRICE ( ) 181.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11319
TODAY'S LOW / HIGH ( )177.00 181.80
52 WK LOW / HIGH ( )72.75 195.55
NSE178.05-5.75 (-3.13 %)
PREV CLOSE( ) 183.80
OPEN PRICE ( ) 181.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 178.05 (48)
VOLUME 54066
TODAY'S LOW / HIGH( ) 177.00 181.25
52 WK LOW / HIGH ( )73.35 196.95
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.962.465.3515.430.00
   CEPS(Rs)5.164.052.103.23
   DPS(Rs)0.450.000.000.000.00
   Book NAV/Share(Rs)24.6821.68192.81187.41
   Tax Rate(%)24.9316.0620.4236.0944.16
Margin Ratios
   Core EBITDA Margin(%)13.1312.148.7211.0511.73
   EBIT Margin(%)10.009.175.277.908.79
   Pre Tax Margin(%)7.407.122.225.686.78
   PAT Margin (%)5.565.981.763.633.79
   Cash Profit Margin (%)9.689.856.907.597.46
Performance Ratios
   ROA(%)4.904.971.203.604.11
   ROE(%)12.8512.022.828.8310.88
   ROCE(%)13.8711.895.9313.0216.05
   Asset Turnover(x)0.880.830.680.991.09
   Sales/Fixed Asset(x)1.101.040.871.261.41
   Working Capital/Sales(x)-18.14-52.11-40.28-14.04-8.55
Efficiency Ratios
   Fixed Capital/Sales(x)0.910.961.150.790.71
   Receivable days39.4641.0758.7750.2844.81
   Inventory Days6.267.048.995.664.47
   Payable days139.27136.02206.34195.01197.24
Valuation Parameters
   PER(x)23.0018.654.150.89
   PCE(x)13.2011.3210.594.27
   Price/Book(x)2.762.121.150.74
   Yield(%)0.660.000.000.00
   EV/Net Sales(x)1.521.380.950.460.19
   EV/Core EBITDA(x)10.7810.609.923.901.49
   EV/EBIT(x)15.2315.0718.085.852.12
   EV/CE(x)1.201.060.640.450.18
   M Cap / Sales1.281.120.730.320.00
Growth Ratio
   Net Sales Growth(%)31.1235.50-28.603.038.70
   Core EBITDA Growth(%)42.0284.11-42.23-1.927.43
   EBIT Growth(%)42.97136.01-52.39-7.426.92
   PAT Growth(%)21.82359.67-65.31-1.25-22.73
   EPS Growth(%)20.24-54.03-65.31-100.00
Financial Stability Ratios
   Total Debt/Equity(x)0.680.600.460.370.53
   Current Ratio(x)0.800.920.910.740.64
   Quick Ratio(x)0.740.830.830.680.60
   Interest Cover(x)3.844.481.733.564.37
   Total Debt/Mcap(x)0.250.280.400.51

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.